Cargando…
SLC7A11, a Potential Therapeutic Target Through Induced Ferroptosis in Colon Adenocarcinoma
Background: Ferroptosis induced by SLC7A11 has an important translational value in the treatment of cancers. However, the mechanism of SLC7A11 in the pathogenesis of colon adenocarcinoma (COAD) is rarely studied in detail. Methods: SLC7A11 expression was explored with The Cancer Genome Atlas (TCGA),...
Autores principales: | Cheng, Xin, Wang, Yadong, Liu, Liangchao, Lv, Chenggang, Liu, Can, Xu, Jingyun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9065265/ https://www.ncbi.nlm.nih.gov/pubmed/35517862 http://dx.doi.org/10.3389/fmolb.2022.889688 |
Ejemplares similares
-
Ferroptosis regulator SLC7A11 is a prognostic marker and correlated with PD-L1 and immune cell infiltration in liver hepatocellular carcinoma
por: Liang, Yimin, et al.
Publicado: (2022) -
Ferroptosis in Chronic Liver Diseases: Opportunities and Challenges
por: Zhou, Xiaoxi, et al.
Publicado: (2022) -
Therapeutic Implications of Ferroptosis in Renal Fibrosis
por: Zhang, Yao, et al.
Publicado: (2022) -
Comprehensive Analysis of Ferroptosis Regulators in Lung Adenocarcinomas Identifies Prognostic and Immunotherapy-Related Biomarkers
por: Sun, Sijin, et al.
Publicado: (2021) -
Recent advances in ferroptosis and therapeutic strategies for glioblastoma
por: Lu, Qixiong, et al.
Publicado: (2023)